Literature DB >> 24516173

Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.

Matthieu Domenech de Cellès1, Maria A Riolo, Felicia M G Magpantay, Pejman Rohani, Aaron A King.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24516173      PMCID: PMC3932918          DOI: 10.1073/pnas.1323795111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  5 in total

1.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

2.  Contact network structure explains the changing epidemiology of pertussis.

Authors:  Pejman Rohani; Xue Zhong; Aaron A King
Journal:  Science       Date:  2010-11-12       Impact factor: 47.728

3.  Can vaccine legacy explain the British pertussis resurgence?

Authors:  Maria A Riolo; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2013-10-16       Impact factor: 3.641

4.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model.

Authors:  Jason M Warfel; Lindsey I Zimmerman; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 5.  Perplexities of pertussis: recent global epidemiological trends and their potential causes.

Authors:  D W Jackson; Pejman Rohani
Journal:  Epidemiol Infect       Date:  2013-01-16       Impact factor: 4.434

  5 in total
  19 in total

Review 1.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

Review 2.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

3.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

4.  Combating pertussis resurgence: One booster vaccination schedule does not fit all.

Authors:  Maria A Riolo; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

5.  Reply to Domenech de Cellès et al.: Infection and transmission of pertussis in the baboon model.

Authors:  Jason M Warfel; Tod J Merkel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

Review 6.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

7.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

8.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

9.  Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.

Authors:  F M G Magpantay; M Domenech DE Cellès; P Rohani; A A King
Journal:  Parasitology       Date:  2015-09-04       Impact factor: 3.234

10.  Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis.

Authors:  Bo-Hyun Cho; Anna M Acosta; Andrew J Leidner; Amanda E Faulkner; Fangjun Zhou
Journal:  Prev Med       Date:  2020-03-19       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.